Breaking News: Smart Decision, Inc. (OTC: SDEC) Signs Letter of Intent (LOI) With HempAmericana, Inc. (OTC: HMPQ) for CBDSmartDecision.com Upcoming CBD Algorithm | Financial Buzz

Breaking News: Smart Decision, Inc. (OTC: SDEC) Signs Letter of Intent (LOI) With HempAmericana, Inc. (OTC: HMPQ) for CBDSmartDecision.com Upcoming CBD Algorithm

Smart Decision, Inc. (OTC: SDEC), a next-generation consumer-based LED & CBD algorithm innovator, is pleased to announce that it has signed a Letter of Intent (LOI) with HempAmericana, Inc., a visionary in the CBD space. 

“We’re excited to have the opportunity to work with HempAmericana. Their operations and CBD manufacturing process are both unique and truly impressive. Hemp Americana’s CEO, Sal Rosillo, is a visionary in both the Cannabis and CBD space. CBDSmartDecision.com will be the first company that HempAmericana, Inc. grants permission to recommend their product range on the affiliate level.  We expect HempAmericana products to provide our company with a steady commission base for years to come. We encourage potential customers to view their products on our site in the near future:  https://cbdsmartdecision.com,” said Adam Green, CEO of Smart Decision, Inc.

Terms of the deal are not being disclosed at this time.

Daily Beast article regarding Sal Rosillio’s meteoric rise in the Cannabis/CBD Industry:

https://www.thedailybeast.com/salvador-rosillo-the-artist-who-made-millions-out-of-marijuana

The growing awareness of cannabidiol or CBD’s health benefits has pushed the market into mainstream retail. CBD is known for its multi-faceted uses such as its ability to alleviate minor conditions like headaches. However, CBD can also be used to treat serious symptoms associated with medical conditions such as cancer, epilepsy, and multiple sclerosis. Moreover, researchers have mentioned that CBD helps with quitting smoking and also mitigates the withdrawal symptoms. Many see legalizing CBD as yet another step to potentially fully legalizing cannabis. According to data compiled by Technavio, the global CBD market is expected to accelerate at a CAGR of 31% during the forecast period from 2018 to 2022.

About Smart Decision Inc. 

Smart Decision Inc. has researched and is developing algorithms for the consumer and business LED Lighting and CBD markets. With their patent-pending “Smart Decision” algorithms, the confusion of selecting the right product(s), whether for LED or CBD, will be significantly reduced. Ultimately, Smart Decision Inc. believes that selecting the right product the first time, dramatically cuts down on product returns and creates of positive purchasing experience for the consumer.

Who can benefit from our Recommendation Algorithm?

  • Consumers – Obviously, the whole basis of our CBD Recommendation Algorithm, is to help consumers select the right CBD product(s) for their needs. Currently, as mentioned earlier, the CBD market is in its “wild-west” phase. Millions of consumers have heard about CBD. Millions of consumers would like to take CBD for their various ailments. However, so many consumers are holding back due to lack of knowledge and lack of what to buy. We believe that 99% of the population needs a pat on the shoulder (advice) when it comes to buying a new type of product. Frankly, most consumers need a push, regardless of what type of product they’re buying. The CBD recommendation algorithm will help provide consumers that added re-assurance they need to take the next step in purchasing CBD for their needs.
  • CBD Manufacturers – Most CBD manufacturers are selling direct to the consumer. Having a CBD Recommendation Algorithm Plugin on their sites, will help consumers stay on their sites and make a buying decision before navigating away to another confusing site.
  • Medical Practices – Medical practices (especially orthopedic practices) are starting to carry and sell CBD products from their offices. While consumers might feel better purchasing CBD from a “medical practice” for obvious reasons, it doesn’t change the fact that doctor’s do not have the familiarity to recommend the right CBD product/dosages for their patients.
  • Online Aggregator – Soon, there will be website(s) that act as a “Price Grabber” for the CBD industry. The group that we have spoken to will launch a site that will offer CBD products from approximately 50 CBD companies. The ability for the average consumer to visit their site and answer a handful of questions (CBD Recommendation Algorithm) to dial-in to a specific product or products that specifically suit the consumer’s need is a big deal to them!
  • Retailers that are selling and starting to sell CBD products (Walgreen’s, Kroger’s and mom & pop retailers & headshops throughout the country.) Besides using our online plug-in that would specifically represent their inventory/product offerings, they could also use the Plug-in with an in-store kiosk/tablet display where consumers could use our algorithm to make buying decisions on the spot.
  • Dispensaries – Recreational & Medical

8 Medical Conditions that CBD can help treat:

  • Pain – CBD can help lower inflammation levels and pain perception. A study published in 2017 in Cannabis and Cannabinoid Research, suggests that CBD might be useful as a pain therapy in place of opioids.
  • Anxiety & Depression – CBD can help with PTSD, generalized anxiety disorders, obsessive-compulsive disorder, and seasonal affective disorder.
  • Epilepsy – CBD can help reduce the number of seizures. (In fact, this is the one condition that the FDA has approved an oral CBD formulation for LGS (Lennox-Gastaut Syndrome) & Dravet Syndrome.
  • Symptoms related to cancer treatment – The focus on CBD for cancer treatment has been for its use in reducing nausea and vomiting that often accompanies chemotherapy and radiation treatments. Researchers at the American Cancer Society have also discovered that CBD may slow the growth of cancer cells.
  • Acne and other skin issues – Researchers believe that topical CBD can be a potent antiacne agent, likely due to its anti- inflammatory properties. Studies have also found that CBD can be useful for reducing the itch and inflammation associated with eczema and psoriasis.
  • High Blood Pressure – Researchers in England have found that even a single dose of CBD can reduce resting blood pressure, which may ultimately reduce the risk of stroke. They concluded that the response may be due to CBD’s anxiety- reducing (anxiolytic) and pain-reducing (analgesic) effects.
  • Addiction – CBD has shown a lot of promise in fighting addiction to everything from opioids and cocaine to alcohol and tobacco.
  • Diabetes – The American Journal of Pathology has suggested that CBD has lowered fasting insulin levels and measures of insulin resistance.

Sponsored Content Release. Click for Full Disclosure

1 Comment
  • Sponsored Content Release

    FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For smart decision inc., financial and corporate news dissemination, FinancialBuzz.com has been compensated four thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.